Related Experiment Video
Updated: Jul 18, 2026

11:45
Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography
Published on: May 26, 2015
Preferential light absorption in atheromas in vitro. Implications for laser angioplasty
The Journal of Clinical Investigation
|July 1, 1986
Summary
Researchers identified a specific light wavelength range (420-530 nm) for selective laser ablation of arterial plaque (atheromas). This finding could improve laser angioplasty by minimizing damage to healthy tissues.
Area of Science:
- Biomedical Optics
- Cardiovascular Research
Background:
- Laser angioplasty ablates arterial obstructions but risks thermal damage to normal tissues.
- Selective light absorption by atheromas is crucial for targeted laser treatment.
Purpose of the Study:
- To identify specific light wavelengths for preferential absorption by human atheromas.
- To assess the potential for selective laser ablation of atherosclerotic lesions.
Main Methods:
- Spectrophotometric analysis of human cadaveric atheromas and normal aorta (250-1,300 nm).
- Evaluation of light transmittance and remittance using integrating sphere and tunable-dye laser.
- Analysis via Kubelka-Munk formalism and Beer's law model; chromophore identification.
Main Results:
- Atheromas showed significantly higher light absorption than normal aorta between 420-530 nm.
- At 470 nm, atheroma absorption coefficient was 54 +/- 9 cm-1, compared to 26 +/- 6 cm-1 for aorta.
- Yellow chromophores, identified as carotenoids, were responsible for preferential atheroma absorption.
Conclusions:
- Carotenoids in atheromas preferentially absorb blue light (420-530 nm).
- This selective absorption enables targeted laser angioplasty, potentially reducing collateral thermal damage.
- Further research into blue light laser parameters for atheroma ablation is warranted.

